In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

On the occasion of World Kidney Day, Manipal Hospital Millers Road, hosted an awareness session to highlight the growing ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...

Dr MKO AbimbolaEnd-stage kidney dis­ease is the last stage (5th stage) of chronic kid­ney disease (CKD). ESRD is also called kidney fail­ure, which develops when the treatment of CKD is either delayed ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave ...

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.

USA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 ...

Use of GLP-1RA therapies in CV/CKD disease with T2D will likely rise as physicians view them as addressers of cardiometabolic ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...